Recomendaciones clínicas basadas en la evidencia sobre cribado del carcinoma oral de células escamosas.

William Carpenter , John R. Kalmar , Frank J. Graham , Mark W. Lingen
Journal of the American Dental Association 5 ( 4) 155 -166

2010
Thyroid Cancer: Molecular Pathogenesis, Tyrosine Kinase Inhibitors, and Other New Therapies

Tiffany N. Tanaka , Ezra E.W. Cohen , Sindura K. Alloju , Deborah K. Oh
American Journal of Hematology / Oncology® 11 ( 4)

2015
Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas.

Julie Frantsve-Hawley , William Carpenter , Bert W. Oettmeier , John R. Kalmar
Texas dental journal 129 ( 5) 491 -507

48
2012
Did Everolimus Break the Rules

Ezra E.W. Cohen , Shumei Kato
Clinical Cancer Research

2021
The next phase of chemoprevention research.

Ezra E.W. Cohen , Richard L. Schilsky
Cancer Prevention Research 4 ( 3) 293 -295

2011
2
2016
2017
Comprehensive analysis of tumor NGS data to demonstrate pathways pointing to therapeutic targeting options.

Subha Krishnan , Ally Perlina , Alex Thomas , Boyko Kakaradov
Journal of Clinical Oncology 35

2017
A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors.

Gini F. Fleming , Ravi Salgia , Navin R. Pinto , Thomas Gajewski
Journal of Clinical Oncology 35

4
2017
An open-label, single-arm, multi-institutional phase II trial of avelumab for recurrent, metastatic nasopharyngeal carcinoma.

Assuntina Gesualda Sacco , Karen Messer , Rom S Leidner , A Dimitrios Colevas
Journal of Clinical Oncology 35

2017
Precision Chemoradiotherapy for HER2 Tumors Using Antibody Conjugates of an Auristatin Derivative with Reduced Cell Permeability.

Dina V. Hingorani , Matthew K. Doan , Maria F. Camargo , Joseph Aguilera
Molecular Cancer Therapeutics 19 ( 1) 157 -167

4
2020
Detection of tumor epidermal growth factor receptor pathway dependence by serum mass spectrometry in cancer patients.

Christine H. Chung , Erin H. Seeley , Heinrich Roder , Julia Grigorieva
Cancer Epidemiology, Biomarkers & Prevention 19 ( 2) 358 -365

56
2010
Selection of Head and Neck Cancer Patients for Intensive Therapy

Lucas K. Vitzthum , Helen Park , Kaveh Zakeri , Alex K. Bryant
International Journal of Radiation Oncology Biology Physics 106 ( 1) 157 -166

3
2020
High Survival and Organ Function Rates After Primary Chemoradiotherapy for Intermediate-Stage Squamous Cell Carcinoma of the Head and Neck Treated in a Multicenter Phase II Trial

Ezra E.W. Cohen , Daniel J. Haraf , Marcy A. List , Masha Kocherginsky
Journal of Clinical Oncology 24 ( 21) 3438 -3444

16
2006
Ex Vivo Antibody-Dependent Cellular Cytotoxicity Inducibility Predicts Efficacy of Cetuximab

Rodney J. Taylor , Vassiliki Saloura , Ajay Jain , Olga Goloubeva
Cancer immunology research 3 ( 5) 567 -574

25
2015
Leveraging TCR Affinity in Adoptive Immunotherapy against Shared Tumor/Self-Antigens

Aaron M. Miller , Milad Bahmanof , Dietmar Zehn , Ezra E.W. Cohen
Cancer immunology research 7 ( 1) 40 -49

10
2019
Epidermal Growth Factor Receptor Inhibitor Gefitinib Added to Chemoradiotherapy in Locally Advanced Head and Neck Cancer

Ezra E.W. Cohen , Daniel J. Haraf , Rangesh Kunnavakkam , Kerstin M. Stenson
Journal of Clinical Oncology 28 ( 20) 3336 -3343

68
2010
The Role of Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma

Tobenna Nwizu , Maria Grazia Ghi , Ezra E.W. Cohen , Adriano Paccagnella
Seminars in Radiation Oncology 22 ( 3) 198 -206

17
2012
Molecular phenotype predicts sensitivity of squamous cell carcinoma of the head and neck to epidermal growth factor receptor inhibition

Natalie R. Young , Jing Liu , Carolyn Pierce , Tai-Fen Wei
Molecular Oncology 7 ( 3) 359 -368

33
2013